Diabetes Foundation Aotearoa community awareness project taking a practical approach to making sure that the newly funded Diabetes Type 2 medications, Empagliflozin and Dulaglutide get to where there are most needed. In 2021, Diabetes Foundation Aotearoa, with funding from Foundation North, worked with Blackland PR to design and run a campaign to increase inquiries by patients to doctors about whether the medications were a better option for them. There is more information on this project here. The results have been published in an article the NZ Medical Journal, Vol 136, No 1572, 2023 Mar 24 Edition. Congratulations Gerhard Sundborn et al on a successful project and publication of the experience.
